73 related articles for article (PubMed ID: 17681061)
1. Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer.
Park JW; Koh DH; Jang WS; Cho KS; Ham WS; Rha KH; Hong SJ; Choi YD
BMC Cancer; 2018 May; 18(1):545. PubMed ID: 29743042
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Relapse of Prostate Cancerafter Radical Prostatectomy in Chinese Population.
You P; Xu L; Tang L; Wang C
Urol J; 2024 May; 21(3):155-161. PubMed ID: 38088088
[TBL] [Abstract][Full Text] [Related]
3. The predictive factor for pathological downgrading after prostatectomy in patients with biopsy Gleason score 4+3 or 4+4 prostate cancer.
Tohi Y; Matsuda I; Fujiwara K; Harada S; Ito A; Yamasaki M; Miyauchi Y; Matsuoka Y; Kato T; Taoka R; Tsunemori H; Ueda N; Sugimoto M
Mol Clin Oncol; 2021 Mar; 14(3):56. PubMed ID: 33604046
[TBL] [Abstract][Full Text] [Related]
4. Risk of adverse pathological features for intermediate risk prostate cancer: Clinical implications for definitive radiation therapy.
Zhang H; Doucette C; Yang H; Bandyopadhyay S; Grossman CE; Messing EM; Chen Y
PLoS One; 2021; 16(7):e0253936. PubMed ID: 34264975
[TBL] [Abstract][Full Text] [Related]
5. PSA density of the lesion: a mathematical formula that uses clinical and pathological data to predict biochemical recurrence in prostate cancer patients.
Junqueira PHR; Santos GAD; Xavier M; Romão P; Reis S; Srougi M; Nahas WC; Passerotti CC
Rev Col Bras Cir; 2021; 48():e20212965. PubMed ID: 34644741
[TBL] [Abstract][Full Text] [Related]
6. Significance of predicted tumor volume as a predictor of pathologic stage in patients undergoing radical prostatectomy.
Ku JH; Moon KC; Kwak C; Kim HH
Korean J Urol; 2011 Jan; 52(1):24-30. PubMed ID: 21344027
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Tumor Volume Parameters on Prostate Cancer Biopsies.
Verhoef EI; Kweldam CF; Kümmerlin IP; Nieboer D; Bangma CH; Incrocci L; van der Kwast TH; Roobol MJ; van Leenders GJLH
Arch Pathol Lab Med; 2020 Jan; ():. PubMed ID: 31904279
[TBL] [Abstract][Full Text] [Related]
8. Positive independent association between preoperative endogenous testosterone density and tumor load density in surgical specimen of patients undergoing radical prostatectomy.
Porcaro AB; Bianchi A; Gallina S; Serafin E; Mazzucato G; Panunzio A; Tafuri A; Montanaro F; Marafioti Patuzzo G; Baielli A; Artoni F; Vidiri S; Cianflone F; D'Aietti D; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
Urologia; 2024 Feb; 91(1):76-84. PubMed ID: 37526101
[TBL] [Abstract][Full Text] [Related]
9. Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancers.
Kryvenko ON; Epstein JI; Merhe A; Iakymenko OA; E Silva RA; Chanamolu DK; Briski LM; Kwon D; Nemov I; Punnen S; Pollack A; Stoyanova R; Parekh DJ; Jorda M; Gonzalgo ML
Am J Clin Pathol; 2024 Feb; ():. PubMed ID: 38412318
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Gleason Pattern 4 at MRI-Guided Biopsy to Predict Adverse Pathology at Radical Prostatectomy in Intermediate-Risk Prostate Cancer Patients.
Kamecki H; Mielczarek Ł; Szempliński S; Dębowska M; Rajwa P; Baboudjian M; Klemm J; Rivas JG; Modzelewska E; Tayara O; Malewski W; Szostek P; Poletajew S; Kryst P; Sosnowski R; Nyk Ł
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001723
[TBL] [Abstract][Full Text] [Related]
11. Differences in the expression of the phosphatase PTP-1B in patients with localized prostate cancer with and without adverse pathological features.
Bourlon MT; Urbina-Ramirez S; Verduzco-Aguirre HC; Mora-Pineda M; Velazquez HE; Leon-Rodriguez E; Atisha-Fregoso Y; De Anda-Gonzalez MG
Front Oncol; 2024; 14():1334845. PubMed ID: 38706600
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic PDE4D7 Score in a Diagnostic Biopsy Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes.
van Strijp D; de Witz C; Vos PC; den Biezen-Timmermans E; van Brussel A; Wrobel J; Baillie GS; Tennstedt P; Schlomm T; Heitkötter B; Huss S; Bögemann M; Houslay MD; Bangma C; Semjonow A; Hoffmann R
Prostate Cancer; 2018; 2018():5821616. PubMed ID: 30147955
[No Abstract] [Full Text] [Related]
13. Amount of Gleason Pattern 3 Is Not Predictive of Risk in Grade Group 2-4 Prostate Cancer.
Vickers AJ; Assel M; Cooperberg MR; Fine SW; Eggener S
Eur Urol; 2024 Jan; ():. PubMed ID: 38278665
[TBL] [Abstract][Full Text] [Related]
14. Calculated tumor volume is an independent predictor of biochemical recurrence in patients who underwent retropubic radical prostatectomy.
Tanaka N; Fujimoto K; Hirayama A; Nakai Y; Chihara Y; Anai S; Tomioka A; Shimada K; Konishi N; Hirao Y
Adv Urol; 2012; 2012():204215. PubMed ID: 22654901
[TBL] [Abstract][Full Text] [Related]
15. Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study.
Tanaka N; Fujimoto K; Hirayama A; Torimoto K; Okajima E; Tanaka M; Miyake M; Shimada K; Konishi N; Hirao Y
Int J Clin Oncol; 2011 Oct; 16(5):553-9. PubMed ID: 21437569
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy in prostate cancer: a risk-adapted strategy.
Hayden AJ; Catton C; Pickles T
Curr Oncol; 2010 Sep; 17 Suppl 2(Suppl 2):S18-24. PubMed ID: 20882127
[TBL] [Abstract][Full Text] [Related]
17. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K
Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061
[TBL] [Abstract][Full Text] [Related]
18. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
[TBL] [Abstract][Full Text] [Related]
19. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
